News Apr 23, 2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
News Apr 04, 2024 Terra Quantum seeking to drive quantum computing innovations in Asia Terra Quantum has its sights set on contributing to the development of quantum-enhanced innovations in Asia. To this end, the St.Gallen-based fir...
News Mar 20, 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
News Mar 28, 2024 Avallain agrees takeover of TeacherMatic Avallain has acquired the London-based firm TeacherMatic. With this takeover, the software specialist for education applications intends to expan...
Actualités Apr 23, 2024 Les orthèses de poignet innovantes imprimées en 3D de Swibrace passent à la phase clinique Swibrace, en partenariat avec l’Inselspital de Berne, fait passer ses attelles de poignet personnalisées en phase clinique, améliorant ainsi le t...
News Mar 06, 2024 Aktiia secures CHF 27 million to combat global hypertension crisis Aktiia, a pioneering Neuchâtel-based start-up specializing in cuffless blood pressure monitoring, has announced a significant financial milestone...
News May 24, 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Actualités Jun 26, 2023 Un vaccin révolutionnaire à base d’ARNm contre le mélanome testé à Genève Le vaccin à ARNm de Moderna contre le mélanome sera testé aux Hôpitaux Universitaires de Genève en 2023. Le vaccin, combiné à l’immunothérapie, p...
News Jun 26, 2023 Revolutionary mRNA vaccine against melanoma to be tested in Geneva Moderna's mRNA vaccine for melanoma will be tested at the Geneva University Hospitals in 2023. The vaccine, combined with immunotherapy, could si...